![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.445, 2004-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide/formoterol breathes QOL into asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 524, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide/formoterol combination superior in COPD
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide/formoterol proves its worth in COPD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 439, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide/formoterol proves its worth in COPD
Inpharma, Vol. 1, Iss. 1414, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide/formoterol makes cents in COPD, asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. :